The MRCT Center and the Petrie-Flom Center at Harvard Law will host Post-Trial Access to Medicines: Responsibilities and Implementation on Sept. 18, 2014. Key questions include:
- How should post-trial access be defined?
- What type of interventions should be included in post-trial access obligations?
- What are the responsibilities of various stakeholders?